Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
The EVP and Chief Medical Officer of Horizon Therapeutics is Exercising Options
02:15am, Saturday, 14'th Mar 2020
Yesterday it was reported that the EVP and Chief Medical Officer of Horizon Therapeutics (HZNP – Research Report), Jeffrey W.
Horizon Therapeutics (NASDAQ:HZNP) Lowered to Buy at BidaskClub
07:40am, Friday, 13'th Mar 2020
Horizon Therapeutics (NASDAQ:HZNP) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Friday, Bid
Capital Analysts LLC Grows Position in Horizon Therapeutics PLC (NASDAQ:HZNP)
09:32am, Wednesday, 11'th Mar 2020
Capital Analysts LLC raised its position in Horizon Therapeutics PLC (NASDAQ:HZNP) by 86.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Ex
Driehaus Capital Management LLC Trims Holdings in Horizon Therapeutics PLC (NASDAQ:HZNP)
10:42am, Monday, 09'th Mar 2020
Driehaus Capital Management LLC trimmed its stake in Horizon Therapeutics PLC (NASDAQ:HZNP) by 18.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 77,
Horizon Therapeutics PLC (NASDAQ:HZNP) Shares Sold by Panagora Asset Management Inc.
10:38am, Monday, 09'th Mar 2020
Panagora Asset Management Inc. lessened its holdings in Horizon Therapeutics PLC (NASDAQ:HZNP) by 10.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. Th
Selecta Biosciences: An Innovative Immunomodulatory Player For 2020
11:30am, Sunday, 08'th Mar 2020
SEL-212 can emerge as game changer in chronic refractory gout indication. ImmTOR is expected to overcome dosing challenges in AAV therapy. Investors should cons
Horizon Therapeutics PLC (NASDAQ:HZNP) Shares Sold by Prudential Financial Inc.
10:20am, Sunday, 08'th Mar 2020
Prudential Financial Inc. trimmed its holdings in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) by 13.9% during the fourth quarter, according to the company in its most recent Form 13F filing with
Comerica Bank Buys Shares of 6,881 Horizon Therapeutics PLC (NASDAQ:HZNP)
08:22am, Sunday, 08'th Mar 2020
Comerica Bank bought a new position in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Comm
Horizon Therapeutics PLC (NASDAQ:HZNP) Given Consensus Recommendation of "Buy" by Analysts
01:16pm, Thursday, 05'th Mar 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) has been assigned a consensus recommendation of “Buy” from the seventeen ratings firms that are currently covering the firm, MarketBeat.com reports. Four ana
BRIEF-India's Lupin Launches Generic Version Of Horizon Therapeutics' Arthritis Drug Vimovo
10:45am, Thursday, 05'th Mar 2020
Lupin Ltd:
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the launch of Down and Out Kidney, a campaign to highlight the damaging effects associated with the accumulation of uric acid and gout in people
Banque Cantonale Vaudoise Acquires New Stake in Horizon Therapeutics PLC (NASDAQ:HZNP)
12:28pm, Tuesday, 03'rd Mar 2020
Banque Cantonale Vaudoise acquired a new stake in Horizon Therapeutics PLC (NASDAQ:HZNP) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 6,299 shares of
Assetmark Inc. Has $3.23 Million Stock Holdings in Horizon Therapeutics PLC (NASDAQ:HZNP)
11:54am, Tuesday, 03'rd Mar 2020
Assetmark Inc. raised its holdings in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) by 76,129.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commiss
Advisory Research Inc. Acquires 8,170 Shares of Horizon Therapeutics PLC (NASDAQ:HZNP)
11:32am, Tuesday, 03'rd Mar 2020
Advisory Research Inc. increased its holdings in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) by 22.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 4
Q1 2020 Earnings Forecast for Horizon Therapeutics PLC (NASDAQ:HZNP) Issued By Piper Sandler
06:44am, Monday, 02'nd Mar 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) – Research analysts at Piper Sandler lowered their Q1 2020 earnings estimates for Horizon Therapeutics in a research report issued to clients and investors on
